Product
Decitabine, Venetoclax, and Blinatumomab
1 clinical trial
1 indication
Indication
B-cell Acute Lymphoblastic LeukemiaClinical trial
A Multicenter, Prospective, Phase II Study of Decitabine, Venetoclax and Blinatumomab for Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Patients With Ph-Negative B-Cell Acute Lymphoblastic LeukemiaStatus: Not yet recruiting, Estimated PCD: 2026-04-25